Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Visitors trend2W10W9M

6.89

-0.08

(-1.15%)

At close: 04:00PM EDT

6.86

-0.03

(-0.44%)

After hours:

07:58PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

MACD

View all chart patterns

Performance Outlook

Previous Close	6.97
Open	7.00
Bid	6.80 x 800
Ask	7.00 x 800
Day's Range	6.84 - 7.00
52 Week Range	6.81 - 15.24
Volume	668,661
Avg. Volume	849,390

Market Cap	564.643M
Beta (5Y Monthly)	0.68
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AVXL

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Anavex Life Sciences Corp.
Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Rating
Fair Value
Economic Moat
3 days agoMorningstar